Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32024-12-19NCT05184335

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Reviva Pharmaceuticals1

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Reviva siteRiversideUnited States1
Reviva sitePhoenixUnited States1
Reviva siteLittle RockUnited States1
Reviva siteChicagoUnited States1
Reviva siteGaithersburgUnited States1
Reviva siteBentonvilleUnited States1
Reviva siteDecaturUnited States1
Reviva siteRogersUnited States1
Reviva siteLemon GroveUnited States1
Reviva siteRichardsonUnited States1
Reviva siteMiami LakesUnited States1
Reviva siteOklahoma CityUnited States1
Reviva siteHollywoodUnited States1
Reviva siteAustinUnited States1
Reviva siteBostonUnited States1
Reviva siteAtlantaUnited States1
Reviva siteHollywoodUnited States1
Reviva siteGarden GroveUnited States1